Detalhe da pesquisa
1.
Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022.
J Korean Med Sci
; 39(5): e43, 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317445
2.
Novel Enhanced Mammalian Cell Transient Expression Vector via Promoter Combination.
Int J Mol Sci
; 25(4)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397006
3.
Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity.
J Med Virol
; 95(12): e29285, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054545
4.
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants.
J Med Virol
; 95(12): e29329, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140877
5.
Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study.
J Korean Med Sci
; 37(27): e210, 2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35818701
6.
Age-Related Differences in Neutralizing Antibody Responses against SARS-CoV-2 Delta and Omicron Variants in 151 SARS-CoV-2-Naïve Metropolitan Residents Boosted with BNT162b2.
J Appl Lab Med
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531067
7.
Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy.
Heliyon
; 10(5): e27211, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468934
8.
Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: implications of immune imprinting and interference.
Clin Microbiol Infect
; 30(5): 653-659, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253313
9.
Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea.
Front Immunol
; 14: 1306604, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193075
10.
Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study.
Vaccines (Basel)
; 11(1)2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36679965
11.
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea.
Infect Chemother
; 55(1): 99-104, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021427
12.
Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations.
Vaccines (Basel)
; 11(8)2023 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37631890
13.
Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device.
Int J Infect Dis
; 128: 112-120, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592685
14.
Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022.
Microbiol Spectr
; : e0165523, 2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37750684
15.
Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample.
Epidemiol Health
; 45: e2023075, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591786
16.
Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey.
Epidemiol Health
; 44: e2022028, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35209706
17.
Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea.
Epidemiol Health
; 44: e2022085, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228670
18.
Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity.
Front Immunol
; 13: 1035441, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700198
19.
COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19.
Front Immunol
; 13: 975363, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119092
20.
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea.
Front Immunol
; 13: 968105, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36211416